CLINICAL_TRIALS
other
· 2025-07-10
Clinical Trial Update: Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers [Phase 2]
Summary
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating adoptive transfer of tumor infiltrating lymphocytes (TIL) for biliary tract cancers, currentl…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Udai Kammula | Conditions: Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 | Status: RECRUITING